-
1Academic Journal
المؤلفون: Kamal Singh, Richa Kumari, Smita Gupta, Rajneesh Tripathi, Anjali Srivastava, Vidisha Shakya, Ankush Gupta, Shampa Anupurba
المصدر: Annals of Clinical Microbiology and Antimicrobials, Vol 20, Iss 1, Pp 1-6 (2021)
مصطلحات موضوعية: GenoType MTBDRsl v.2.0 assay, Fluoroquinolones (FQs), Second-line injectable drugs (SLIDs), RR-TB, MDR-TB, XDR-TB, Therapeutics. Pharmacology, RM1-950, Infectious and parasitic diseases, RC109-216, Microbiology, QR1-502
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1476-0711
-
2Academic Journal
المؤلفون: Cheng S, Hide M, Pheng SH, Kerléguer A, Delvallez G, Sam S, Mao TE, Nguyen TVA, Bañuls AL
المصدر: Infection and Drug Resistance, Vol Volume 14, Pp 1089-1104 (2021)
مصطلحات موضوعية: mycobacterium tuberculosis, extensively drug-resistant tuberculosis, pre-extensively drug-resistant tuberculosis, fluoroquinolone, second-line injectable drugs., Infectious and parasitic diseases, RC109-216
وصف الملف: electronic resource
Relation: https://www.dovepress.com/resistance-to-second-line-anti-tb-drugs-in-cambodia-a-phenotypic-and-g-peer-reviewed-article-IDR; https://doaj.org/toc/1178-6973
-
3Academic Journal
المصدر: Infection and Drug Resistance, Vol Volume 13, Pp 4091-4104 (2020)
مصطلحات موضوعية: mycobacterium tuberculosis, drug resistance, reverse dot blot hybridization, fluoroquinolones, second-line injectable drugs, ofloxacin, kanamycin, amikacin, capreomycin, Infectious and parasitic diseases, RC109-216
وصف الملف: electronic resource
Relation: https://www.dovepress.com/detection-of-resistance-to-fluoroquinolones-and-second-line-injectable-peer-reviewed-article-IDR; https://doaj.org/toc/1178-6973
-
4Academic Journal
المؤلفون: Cheng, Sokleaph, Hide, Mallorie, Pheng, Sok Heng, Kerléguer, Alexandra, Delvallez, Gauthier, Sam, Sophan, Mao, Tan Eang, Nguyen, Thi van Anh, Bañuls, Anne-Laure
المساهمون: Institut Pasteur du Cambodge, Pasteur Network (Réseau International des Instituts Pasteur), Ministry of Health Phnom Penh, Unité de biologie médicale - Medical biology unit Phnom Penh, Cambodia, Pasteur Network (Réseau International des Instituts Pasteur)-Pasteur Network (Réseau International des Instituts Pasteur), Du gène à l'écosystème (MIVEGEC-GeneSys), Pathogènes, Environnement, Santé Humaine (EPATH), Maladies infectieuses et vecteurs : écologie, génétique, évolution et contrôle (MIVEGEC), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD Occitanie )-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD Occitanie )-Maladies infectieuses et vecteurs : écologie, génétique, évolution et contrôle (MIVEGEC), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD Occitanie )-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD Occitanie ), Centre de Recherche en Ecologie et Evolution de la Santé (CREES), Institut de Recherche pour le Développement (IRD)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), National Center for Tuberculosis and Leprosy Control Phnom Penh, Cambodia (CENAT), Cambodian Health Committee, National Institute of Hygiene and Epidemiology / Institut National d'Hygiène et d'Épidémiologie Hanoi, Vietnam (NIHE), This study was funded by the project of the International Joint Laboratory on Drug Resistance in South-East Asia (LMI DRISA), the French Embassy in Cambodia, the Cambodian Ministry of Education, Youth and Sports (MoEYS) and the PHC Lotus project “Application of DNA chip technology for the development of diagnostic kits for rapid detection of drug‐resistant tuberculosis in Vietnam, Laos and Cambodia (2014–2018)” granted by the Ministry of Science and Technology (MOST) and the French Embassy, Vietnam. Sokleaph Cheng, PhD, was funded by the IRD PhD Grant program, ARTS.
المصدر: ISSN: 1178-6973 ; Infection and Drug Resistance ; https://hal.science/hal-03204662 ; Infection and Drug Resistance, 2021, Volume 14, pp.1089-1104. ⟨10.2147/IDR.S289907⟩.
مصطلحات موضوعية: Mycobacterium tuberculosis, extensively drug-resistant tuberculosis, pre-extensively drug-resistant tuberculosis, fluoroquinolone, second-line injectable drugs, [SDV]Life Sciences [q-bio]
Relation: info:eu-repo/semantics/altIdentifier/pmid/33762833; IRD: fdi:010081158; PUBMED: 33762833; PUBMEDCENTRAL: PMC7982564
-
5Academic Journal
المؤلفون: Kamal Singh (9287960), Richa Kumari (3148437), Smita Gupta (625103), Rajneesh Tripathi (3148431), Anjali Srivastava (11339841), Vidisha Shakya (11339844), Ankush Gupta (690620), Shampa Anupurba (11339847)
مصطلحات موضوعية: Microbiology, Pharmacology, Biotechnology, Cancer, Science Policy, Hematology, Infectious Diseases, Virology, Environmental Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, GenoType MTBDRsl v.2.0 assay, Fluoroquinolones (FQs), Second-line injectable drugs (SLIDs), RR-TB, MDR-TB, XDR-TB
-
6Academic Journal
المؤلفون: Olena Oliveira (6902450), Rita Gaio (700046), Margarida Correia-Neves (125215), Teresa Rito (393568), Raquel Duarte (3124080)
مصطلحات موضوعية: Medicine, Cell Biology, Neuroscience, Pharmacology, Biotechnology, Immunology, Cancer, Science Policy, Infectious Diseases, Environmental Sciences not elsewhere classified, MDR-TB, injectable drug use, treatment success rate, 142 XDR-TB patients, MDR, CI, second-line injectable drugs, TB Surveillance System, treatment outcomes, HIV infection, drug-resistant tuberculosis treatme., XDR-TB patients
-
7Academic Journal
المؤلفون: Olena Oliveira (6902450), Rita Gaio (700046), Margarida Correia-Neves (125215), Teresa Rito (393568), Raquel Duarte (3124080)
مصطلحات موضوعية: Medicine, Cell Biology, Neuroscience, Pharmacology, Biotechnology, Immunology, Cancer, Science Policy, Infectious Diseases, Environmental Sciences not elsewhere classified, MDR-TB, injectable drug use, treatment success rate, 142 XDR-TB patients, MDR, CI, second-line injectable drugs, TB Surveillance System, treatment outcomes, HIV infection, drug-resistant tuberculosis treatme., XDR-TB patients
-
8Academic Journal
المؤلفون: Agonafir, Mulualem, Belay, Gurja, Feleke, Adey, Maningi, Nontuthuko Excellent, Girmachew, Feven, Reta, Melese Abate, Fourie, P.B. (Petrus Bernardus)
مصطلحات موضوعية: Ethiopia, Line probe assay, Mutation, Tuberculosis (TB), Drug-resistant tuberculosis (DRTB), Mycobacterium tuberculosis (MTB), Rifampicin (RIF), Isoniazid (INH), Second-line injectable drugs (SLIDs), fluoroquinolones (FLQs), SDG-03: Good health and well-being
وصف الملف: application/pdf
Relation: Agonafir, M., Belay, G., Feleke, A 2023, 'Profile and frequency of mutations conferring drug-resistant tuberculosis in the central, southeastern and eastern Ethiopia', Infection and Drug Resistance, vol. 2023, no. 16, pp. 2953-2961. https://DOI.org/10.2147/IDR.S408567.; http://hdl.handle.net/2263/97301
-
9
المؤلفون: Anne-Laure Bañuls, Sokleaph Cheng, Thi Van Anh Nguyen, Sophan Sam, Mallorie Hide, Sok Heng Pheng, Tan Eang Mao, Gauthier Delvallez, Alexandra Kerleguer
المساهمون: Institut Pasteur du Cambodge, Réseau International des Instituts Pasteur (RIIP), Ministry of Health [Phnom Penh], Unité de biologie médicale - Medical biology unit [Phnom Penh, Cambodia], Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Du gène à l'écosystème (MIVEGEC-GeneSys), Pathogènes, Environnement, Santé Humaine (EPATH), Maladies infectieuses et vecteurs : écologie, génétique, évolution et contrôle (MIVEGEC), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud])-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud])-Maladies infectieuses et vecteurs : écologie, génétique, évolution et contrôle (MIVEGEC), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud])-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud]), Centre de Recherche en Ecologie et Evolution de la Santé (CREES), Institut de Recherche pour le Développement (IRD)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), National Center for Tuberculosis and Leprosy Control [Phnom Penh, Cambodia] (CENAT), Cambodian Health Committee, National Institute of Hygiene and Epidemiology [Hanoi, Vietnam] (NIHE), This study was funded by the project of the International Joint Laboratory on Drug Resistance in South-East Asia (LMI DRISA), the French Embassy in Cambodia, the Cambodian Ministry of Education, Youth and Sports (MoEYS) and the PHC Lotus project 'Application of DNA chip technology for the development of diagnostic kits for rapid detection of drug‐resistant tuberculosis in Vietnam, Laos and Cambodia (2014–2018)' granted by the Ministry of Science and Technology (MOST) and the French Embassy, Vietnam. Sokleaph Cheng, PhD, was funded by the IRD PhD Grant program, ARTS.
المصدر: Infection and Drug Resistance
Infection and Drug Resistance, Dove Medical Press, 2021, Volume 14, pp.1089-1104. ⟨10.2147/IDR.S289907⟩
Infection and Drug Resistance, 2021, Volume 14, pp.1089-1104. ⟨10.2147/IDR.S289907⟩مصطلحات موضوعية: 0301 basic medicine, [SDV]Life Sciences [q-bio], 030106 microbiology, Population, Biology, fluoroquinolone, pre-extensively drug-resistant tuberculosis, Mycobacterium tuberculosis, 03 medical and health sciences, 0302 clinical medicine, Genotype, medicine, extensively drug-resistant tuberculosis, Pharmacology (medical), 030212 general & internal medicine, education, Original Research, second-line injectable drugs, Pharmacology, education.field_of_study, Strain (biology), Extensively drug-resistant tuberculosis, Pyrazinamide, biology.organism_classification, medicine.disease, Virology, Phenotype, 3. Good health, Infectious Diseases, Infection and Drug Resistance, Pre-Extensively Drug-Resistant Tuberculosis, medicine.drug
وصف الملف: text/html
-
10Academic Journal
المؤلفون: Malinga, Lesibana Anthony, Brand, Jeannette, Olorunju, Steve, Stoltz, Anton Carel, Van der Walt, Martie
مصطلحات موضوعية: rrs Gene, G878A mutation, Cross-resistance, Second-line injectable drugs (SLIDs), Mycobacterium tuberculosis (MTB)
Relation: http://hdl.handle.net/2263/56607; Malinga, L, Brand, J, Olorunju, S, Stoltz, A & Van der Walt, M 2016, 'Molecular analysis of genetic mutations among cross-resistant second-line injectable drugs reveals a new resistant mutation in Mycobacterium tuberculosis', Diagnostic Microbiology and Infectious Disease, vol. 85, no. 4, pp. 433-437.; 0732-8893 (print); 1879-0070 (online)
-
11Academic Journal
المؤلفون: Cheng, S., Hide, M., Pheng, S. H., Kerleguer, A., Delvallez, G., Sam, S., Mao, T. E., Nguyen, T. V. A., /Banuls, Anne-Laure
مصطلحات موضوعية: Mycobacterium tuberculosis, extensively drug-resistant tuberculosis, pre-extensively drug-resistant tuberculosis, fluoroquinolone, second-line injectable drugs
جغرافية الموضوع: CAMBODGE
Relation: https://www.documentation.ird.fr/hor/fdi:010081158; oai:ird.fr:fdi:010081158; Cheng S., Hide M., Pheng S. H., Kerleguer A., Delvallez G., Sam S., Mao T. E., Nguyen T. V. A., Banuls Anne-Laure. Resistance to second-line anti-TB drugs in Cambodia : a phenotypic and genetic study. 2021, 14, p. 1089-1104
-
12
المؤلفون: Vidisha Shakya, Rajneesh Tripathi, Anjali Srivastava, Ankush Gupta, Shampa Anupurba, Smita Gupta, Kamal Singh, Richa Kumari
المصدر: Annals of Clinical Microbiology and Antimicrobials
Annals of Clinical Microbiology and Antimicrobials, Vol 20, Iss 1, Pp 1-6 (2021)مصطلحات موضوعية: Microbiology (medical), Tuberculosis, Genotype, Extensively Drug-Resistant Tuberculosis, Antitubercular Agents, India, GenoType MTBDRsl v.2.0 assay, MDR-TB, RM1-950, Infectious and parasitic diseases, RC109-216, Drug resistance, Microbial Sensitivity Tests, Microbiology, Antibiotic resistance, medicine, Humans, Second-line injectable drugs (SLIDs), XDR-TB, GeneXpert MTB/RIF, biology, business.industry, Research, Fluoroquinolones (FQs), RR-TB, Sputum, General Medicine, Mycobacterium tuberculosis, medicine.disease, biology.organism_classification, QR1-502, Infectious Diseases, Mycobacterium tuberculosis complex, Therapeutics. Pharmacology, Ofloxacin, medicine.symptom, business, medicine.drug, Fluoroquinolones
-
13
المؤلفون: Guilian, Li, Qian, Guo, Haican, Liu, Li, Wan, Yi, Jiang, Machao, Li, Li-Li, Zhao, Xiuqin, Zhao, Zhiguang, Liu, Kanglin, Wan
المصدر: Infection and Drug Resistance
مصطلحات موضوعية: capreomycin, kanamycin, drug resistance, reverse dot blot hybridization, amikacin, ofloxacin, Mycobacterium tuberculosis, fluoroquinolones, Original Research, second-line injectable drugs
-
14
المؤلفون: Olena Oliveira (6902450), Rita Gaio (700046), Margarida Correia-Neves (125215), Teresa Rito (393568), Raquel Duarte (3124080)
مصطلحات موضوعية: Medicine, Cell Biology, Neuroscience, Pharmacology, Biotechnology, Immunology, Cancer, Science Policy, Infectious Diseases, Environmental Sciences not elsewhere classified, MDR-TB, injectable drug use, treatment success rate, 142 XDR-TB patients, MDR, CI, second-line injectable drugs, TB Surveillance System, treatment outcomes, HIV infection, drug-resistant tuberculosis treatme., XDR-TB patients
-
15
المؤلفون: Olena Oliveira (6902450), Rita Gaio (700046), Margarida Correia-Neves (125215), Teresa Rito (393568), Raquel Duarte (3124080)
مصطلحات موضوعية: Medicine, Cell Biology, Neuroscience, Pharmacology, Biotechnology, Immunology, Cancer, Science Policy, Infectious Diseases, Environmental Sciences not elsewhere classified, MDR-TB, injectable drug use, treatment success rate, 142 XDR-TB patients, MDR, CI, second-line injectable drugs, TB Surveillance System, treatment outcomes, HIV infection, drug-resistant tuberculosis treatme., XDR-TB patients
-
16Image
المؤلفون: Olena Oliveira (6902450), Rita Gaio (700046), Margarida Correia-Neves (125215), Teresa Rito (393568), Raquel Duarte (3124080)
مصطلحات موضوعية: Medicine, Cell Biology, Neuroscience, Pharmacology, Biotechnology, Immunology, Cancer, Science Policy, Infectious Diseases, Environmental Sciences not elsewhere classified, MDR-TB, injectable drug use, treatment success rate, 142 XDR-TB patients, MDR, CI, second-line injectable drugs, TB Surveillance System, treatment outcomes, HIV infection, drug-resistant tuberculosis treatme., XDR-TB patients
-
17
المؤلفون: Olena Oliveira (6902450), Rita Gaio (700046), Margarida Correia-Neves (125215), Teresa Rito (393568), Raquel Duarte (3124080)
مصطلحات موضوعية: Medicine, Cell Biology, Neuroscience, Pharmacology, Biotechnology, Immunology, Cancer, Science Policy, Infectious Diseases, Environmental Sciences not elsewhere classified, MDR-TB, injectable drug use, treatment success rate, 142 XDR-TB patients, MDR, CI, second-line injectable drugs, TB Surveillance System, treatment outcomes, HIV infection, drug-resistant tuberculosis treatme., XDR-TB patients
-
18Image
المؤلفون: Olena Oliveira (6902450), Rita Gaio (700046), Margarida Correia-Neves (125215), Teresa Rito (393568), Raquel Duarte (3124080)
مصطلحات موضوعية: Medicine, Cell Biology, Neuroscience, Pharmacology, Biotechnology, Immunology, Cancer, Science Policy, Infectious Diseases, Environmental Sciences not elsewhere classified, MDR-TB, injectable drug use, treatment success rate, 142 XDR-TB patients, MDR, CI, second-line injectable drugs, TB Surveillance System, treatment outcomes, HIV infection, drug-resistant tuberculosis treatme., XDR-TB patients
-
19
المؤلفون: Olena Oliveira (6902450), Rita Gaio (700046), Margarida Correia-Neves (125215), Teresa Rito (393568), Raquel Duarte (3124080)
مصطلحات موضوعية: Medicine, Cell Biology, Neuroscience, Pharmacology, Biotechnology, Immunology, Cancer, Science Policy, Infectious Diseases, Environmental Sciences not elsewhere classified, MDR-TB, injectable drug use, treatment success rate, 142 XDR-TB patients, MDR, CI, second-line injectable drugs, TB Surveillance System, treatment outcomes, HIV infection, drug-resistant tuberculosis treatme., XDR-TB patients
-
20Factors associated with death among patients with extensively drug-resistant tuberculosis (n = 142).
المؤلفون: Olena Oliveira (6902450), Rita Gaio (700046), Margarida Correia-Neves (125215), Teresa Rito (393568), Raquel Duarte (3124080)
مصطلحات موضوعية: Medicine, Cell Biology, Neuroscience, Pharmacology, Biotechnology, Immunology, Cancer, Science Policy, Infectious Diseases, Environmental Sciences not elsewhere classified, MDR-TB, injectable drug use, treatment success rate, 142 XDR-TB patients, MDR, CI, second-line injectable drugs, TB Surveillance System, treatment outcomes, HIV infection, drug-resistant tuberculosis treatme., XDR-TB patients